Blake Wise, Novome Biotechnologies CEO
Genentech-partnered Novome lands $43.5M to push gastrointestinal drug through mid-stage study
A biotech with connections to Roche’s Genentech has now landed its newest cash infusion.
Microbiome outfit Novome Biotechnologies said Tuesday that it has now secured …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
